Kite Pharma
The Director, Payer & Value Marketing leads the portfolio-level payer and value marketing strategy for Kite's US cell therapy portfolio, focusing on developing evidence-based resources and tools to support appropriate access to products. This role involves collaborating with cross-functional teams to ensure strategies are compliant, customer-relevant, and aligned with broader business objectives. The position requires leading a team to drive payer engagement, optimize value communication, and support market access goals across various stakeholders.
Headquarters
Santa Monica, California, United States
Company Size
1001-5000 employees
Founded
2009
Kite Pharma is a biotechnology company focused on developing cell therapies to treat cancer, specializing in engineered T‑cell (CAR‑T) approaches. The company advances programs from basic science through clinical trials and commercialization, maintaining an active pipeline of therapies for hematologic and solid tumors. Kite also provides patient resources, treatment center networks, and access programs to support therapy delivery. It operates as part of Gilead Sciences, leveraging global capabilities to accelerate curative cancer treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kite Pharma.
11% above the average for this role
Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune
Gilead Sciences
Director, US Value & Access
ionis
Director / Senior Director Payer Marketing
MoonLake Immunotherapeutics
Director, Value Strategy & Marketing - Rare Disease & Oncology
Amgen
Director, HEOR & Value Evidence
Telix Pharmaceuticals
US Medical Early Asset Director – Market Access
AstraZeneca